Physician profile
Yuriy Moklyak
NPI 1588084339
$18,912.27
in general payments reported to CMS, 2019-2025
13 companies · $630 in 2025
The $630 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $330 · 2022: $14K · 2023: $2,041 · 2024: $2,044 · 2025: $630.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,934 · Travel and Lodging: $1,738 · Gift: $43.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,933.72 |
| Travel and Lodging | $1,738.13 |
| Gift | $43.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,223.79 | 2022-2025 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $376.22 | 2024-2025 | Oasis, Grafix Pl, Stravix |
| Kerecis Limited | $338.60 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Medical Device Business Services, INC. | $329.99 | 2020 | |
| Davol INC. | $235.54 | 2023-2024 | Phasix Mesh |
| Baxter Healthcare | $137.50 | 2023 | Floseal |
| Mimedx Group, INC. | $114.99 | 2025 | |
| Integra Lifesciences Corporation | $40.03 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Conmed Corporation | $33.33 | 2023 | Airseal |
| Mozarc Medical US LLC | $24.99 | 2023 | Argyle |
| Heron Therapeutics, INC. | $22.42 | 2023 | Zynrelef |
| Solventum Corporation | $19.45 | 2025 | Activ.A.C., V.A.C. Veraflo |
| Pacira Pharmaceuticals Incorporated | $15.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yuriy Moklyak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.